Introduction: Pulmonary actinomycosis, clinically and radiologically, mimics abscess, tuberculosis, and lung malignancy, resulting in misdiagnosis or delay in diagnosis. In this study, we analyzed the clinicoradiological features of pulmonary actinomycosis, the presence of any differences between clinical prediagnosis and radiological diagnosis, and whether imaging modalities help distinguish pulmonary actinomycosis from lung cancer.

Methods: A total of 22 patients who had a histopathological diagnosis of actinomycosis in a tertiary health center participated in this study. Of these, 14 had positron-emission tomography/computed tomography.

Results: In all, 81.8% of the patients were males. The diagnostic procedures employed for the diagnosis of actinomycosis were surgery in 54.5% of patients, fiberoptic bronchoscopy in 36.4% of patients, and rigid bronchoscopy in 9.1% of patients. Radiological and clinical prediagnosis showed malignancy in 31.8 and 40.9% of patients, respectively. The mean of the maximum standardized uptake value was 6.33±3.6 on positron-emission tomography/computed tomography. Kappa compliance analysis revealed that clinical and radiological diagnoses were significantly compatible with each other and that radiological pre-diagnoses were not superior to clinical diagnoses (κ=0.701 and p<0.001).

Conclusion: Pulmonary actinomycosis shows high metabolic uptake in positron-emission tomography/computed tomography, and this may mislead clinicians for a diagnosis of malignancy. Our results suggest that positron-emission tomography/computed tomography does not help distinguish pulmonary actinomycosis from lung malignancy and does not provide a clear diagnostic benefit to the clinician, so pathological diagnosis is necessary.

Download full-text PDF

Source
http://dx.doi.org/10.1590/1806-9282.20211017DOI Listing

Publication Analysis

Top Keywords

pulmonary actinomycosis
16
clinical radiological
8
lung malignancy
8
clinical prediagnosis
8
diagnosis actinomycosis
8
positron-emission tomography/computed
8
actinomycosis
6
patients
6
clinical
5
radiological characteristics
4

Similar Publications

Pulmonary infection caused by Tropheryma whipplei: a case report and review of the literature.

J Med Case Rep

December 2024

Jiangxi Medical Center for Critical Public Health Events, The First Affiliated Hospital of Nanchang University, Nanchang, 330052, Jiangxi, People's Republic of China.

Background: Tropheryma whipplei pneumonia is an infrequent medical condition. The clinical symptoms associated with this disease are nonspecific, often resulting in misdiagnosis or missed diagnosis. Therefore, sharing and summarizing the experiences in the diagnosis and treatment of this disease can deepen global understanding and awareness of it.

View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary actinomycosis is a rare lung infection caused by the bacterium Actinomyces and is often misdiagnosed as pulmonary tuberculosis or lung cancer due to its uncommon pulmonary presence.
  • Endobronchial actinomycosis, where the infection occurs in the bronchial tubes, is very rare, and there have been instances of broncholithiasis (calcium stones in the bronchial tubes) linked to it.
  • A case study of a 50-year-old male presenting with cough and hemoptysis (coughing up blood) revealed he had endobronchial actinomycosis with broncholithiasis, confirmed through a transbronchial biopsy.
View Article and Find Full Text PDF

This report describes the case of a 41-year-old male patient complaining of a hacking cough. The patient was treated with a Janus kinase (JAK) inhibitor for psoriasis. Blood tests revealed mild lymphopenia and high levels of serum cryptococcal antigen.

View Article and Find Full Text PDF
Article Synopsis
  • - A case study reports a 48-year-old male smoker who developed pyopneumothorax after experiencing pneumonia caused by COVID-19, requiring oxygen support and antibiotic treatment.
  • - After initial recovery, he experienced hemoptysis, leading to a diagnosis of actinomycosis through endoscopic biopsy histopathology.
  • - The patient responded well to prolonged antibiotic therapy with amoxicillin, highlighting the need to consider pulmonary actinomycosis in patients displaying lasting respiratory symptoms post-COVID-19.
View Article and Find Full Text PDF

Rationale: Pulmonary sequestration (PS), a rare pulmonary disease, arises from congenital pulmonary vascular dysplasia. Meanwhile, pulmonary actinomycosis is a purulent infection of lung lesions triggered by the inhalation of actinomycetes, which is also uncommon. Even rarer is the occurrence of pulmonary actinomycete infection secondary to PS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!